RU2589681C2 - Неинвазивное обнаружение генетической аномалии плода - Google Patents
Неинвазивное обнаружение генетической аномалии плода Download PDFInfo
- Publication number
- RU2589681C2 RU2589681C2 RU2012158107/15A RU2012158107A RU2589681C2 RU 2589681 C2 RU2589681 C2 RU 2589681C2 RU 2012158107/15 A RU2012158107/15 A RU 2012158107/15A RU 2012158107 A RU2012158107 A RU 2012158107A RU 2589681 C2 RU2589681 C2 RU 2589681C2
- Authority
- RU
- Russia
- Prior art keywords
- chromosome
- content
- depth
- coating depth
- sample
- Prior art date
Links
- 230000002068 genetic effect Effects 0.000 title claims abstract description 29
- 230000005856 abnormality Effects 0.000 title claims description 29
- 238000001514 detection method Methods 0.000 title abstract description 20
- 210000000349 chromosome Anatomy 0.000 claims abstract description 241
- 239000011248 coating agent Substances 0.000 claims abstract description 124
- 238000000576 coating method Methods 0.000 claims abstract description 124
- 238000000034 method Methods 0.000 claims abstract description 78
- 239000012634 fragment Substances 0.000 claims abstract description 67
- 208000036878 aneuploidy Diseases 0.000 claims abstract description 49
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 45
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 45
- 239000002157 polynucleotide Substances 0.000 claims abstract description 45
- 231100001075 aneuploidy Toxicity 0.000 claims abstract description 39
- 210000005259 peripheral blood Anatomy 0.000 claims abstract description 4
- 239000011886 peripheral blood Substances 0.000 claims abstract description 4
- 210000003754 fetus Anatomy 0.000 claims description 75
- 230000001605 fetal effect Effects 0.000 claims description 41
- 238000009826 distribution Methods 0.000 claims description 25
- 208000037280 Trisomy Diseases 0.000 claims description 19
- 230000008774 maternal effect Effects 0.000 claims description 16
- 206010053884 trisomy 18 Diseases 0.000 claims description 16
- 201000010374 Down Syndrome Diseases 0.000 claims description 15
- 201000006360 Edwards syndrome Diseases 0.000 claims description 15
- 208000007159 Trisomy 18 Syndrome Diseases 0.000 claims description 15
- 206010044688 Trisomy 21 Diseases 0.000 claims description 14
- 210000003765 sex chromosome Anatomy 0.000 claims description 12
- 201000009928 Patau syndrome Diseases 0.000 claims description 11
- 206010044686 Trisomy 13 Diseases 0.000 claims description 11
- 208000006284 Trisomy 13 Syndrome Diseases 0.000 claims description 11
- 230000003322 aneuploid effect Effects 0.000 claims description 10
- 238000000551 statistical hypothesis test Methods 0.000 claims description 4
- 230000002759 chromosomal effect Effects 0.000 claims 2
- 241000282414 Homo sapiens Species 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 5
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 74
- 239000000523 sample Substances 0.000 description 48
- 238000012163 sequencing technique Methods 0.000 description 44
- 230000035945 sensitivity Effects 0.000 description 37
- 230000000875 corresponding effect Effects 0.000 description 25
- 238000013459 approach Methods 0.000 description 23
- 210000002381 plasma Anatomy 0.000 description 17
- 239000012472 biological sample Substances 0.000 description 14
- 150000007523 nucleic acids Chemical class 0.000 description 12
- 102000039446 nucleic acids Human genes 0.000 description 11
- 108020004707 nucleic acids Proteins 0.000 description 11
- 208000031404 Chromosome Aberrations Diseases 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 230000035935 pregnancy Effects 0.000 description 7
- 210000001766 X chromosome Anatomy 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000012937 correction Methods 0.000 description 6
- 238000003793 prenatal diagnosis Methods 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 238000000692 Student's t-test Methods 0.000 description 5
- 210000002593 Y chromosome Anatomy 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000001712 DNA sequencing Methods 0.000 description 4
- 208000017924 Klinefelter Syndrome Diseases 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 208000037492 Sex Chromosome Aberrations Diseases 0.000 description 4
- 208000026928 Turner syndrome Diseases 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 208000030454 monosomy Diseases 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- -1 their analogs Substances 0.000 description 4
- 206010008805 Chromosomal abnormalities Diseases 0.000 description 3
- 238000004422 calculation algorithm Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 210000002308 embryonic cell Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000012353 t test Methods 0.000 description 3
- 208000026817 47,XYY syndrome Diseases 0.000 description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 description 2
- 208000007466 Male Infertility Diseases 0.000 description 2
- 208000020584 Polyploidy Diseases 0.000 description 2
- 208000027399 Sex Chromosome disease Diseases 0.000 description 2
- 206010061513 Sex chromosome abnormality Diseases 0.000 description 2
- 108020004566 Transfer RNA Proteins 0.000 description 2
- 206010056894 XYY syndrome Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 208000016361 genetic disease Diseases 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 150000008298 phosphoramidates Chemical class 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000036266 weeks of gestation Effects 0.000 description 2
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- 101001007348 Arachis hypogaea Galactose-binding lectin Proteins 0.000 description 1
- 208000018311 Autosomal trisomy Diseases 0.000 description 1
- 241001520764 Betula pubescens Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 108091028026 C-DNA Proteins 0.000 description 1
- 229930182476 C-glycoside Natural products 0.000 description 1
- 150000000700 C-glycosides Chemical class 0.000 description 1
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- 208000031639 Chromosome Deletion Diseases 0.000 description 1
- 208000011359 Chromosome disease Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000016679 Monosomy X Diseases 0.000 description 1
- 102100030569 Nuclear receptor corepressor 2 Human genes 0.000 description 1
- 101710153660 Nuclear receptor corepressor 2 Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 238000001190 Q-PCR Methods 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 235000014548 Rubus moluccanus Nutrition 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 208000035199 Tetraploidy Diseases 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 208000026487 Triploidy Diseases 0.000 description 1
- 206010071762 Trisomy 14 Diseases 0.000 description 1
- 206010062757 Trisomy 15 Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 238000002669 amniocentesis Methods 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000004252 chorionic villi Anatomy 0.000 description 1
- 208000024971 chromosomal disease Diseases 0.000 description 1
- 208000015241 chromosome 13q trisomy Diseases 0.000 description 1
- 208000037516 chromosome inversion disease Diseases 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 108700020302 erbB-2 Genes Proteins 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000007672 fourth generation sequencing Methods 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003917 human chromosome Anatomy 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000012177 large-scale sequencing Methods 0.000 description 1
- 238000007477 logistic regression Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical class CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
- 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 201000003738 orofaciodigital syndrome VIII Diseases 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 208000010602 partial trisomy of the long arm of chromosome 18 Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- IGFXRKMLLMBKSA-UHFFFAOYSA-N purine Chemical compound N1=C[N]C2=NC=NC2=C1 IGFXRKMLLMBKSA-UHFFFAOYSA-N 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000013179 statistical model Methods 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 208000027223 tetraploidy syndrome Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 206010044689 trisomy 22 Diseases 0.000 description 1
- 210000002993 trophoblast Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2011/001070 WO2013000100A1 (en) | 2011-06-29 | 2011-06-29 | Noninvasive detection of fetal genetic abnormality |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2012158107A RU2012158107A (ru) | 2015-08-10 |
| RU2589681C2 true RU2589681C2 (ru) | 2016-07-10 |
Family
ID=47392194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012158107/15A RU2589681C2 (ru) | 2011-06-29 | 2011-06-29 | Неинвазивное обнаружение генетической аномалии плода |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9547748B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2561103B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5659319B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101489568B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN103403183B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012261664B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112012033760B1 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2791118C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2561103T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2512448T3 (cg-RX-API-DMAC7.html) |
| MY (1) | MY172864A (cg-RX-API-DMAC7.html) |
| PL (1) | PL2561103T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2589681C2 (cg-RX-API-DMAC7.html) |
| SG (1) | SG191757A1 (cg-RX-API-DMAC7.html) |
| SI (1) | SI2561103T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013000100A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201209583B (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2752783C1 (ru) * | 2020-12-18 | 2021-08-03 | Федеральное государственное бюджетное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Министерства здравоохранения Российской Федерации | Способ прогнозирования анеуплоидии эмбрионов в программе экстракорпорального оплодотворения у женщин с эндометриоз-ассоциированным бесплодием |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11270781B2 (en) | 2011-01-25 | 2022-03-08 | Ariosa Diagnostics, Inc. | Statistical analysis for non-invasive sex chromosome aneuploidy determination |
| US20140235474A1 (en) | 2011-06-24 | 2014-08-21 | Sequenom, Inc. | Methods and processes for non invasive assessment of a genetic variation |
| CN103403183B (zh) | 2011-06-29 | 2014-10-15 | 深圳华大基因医学有限公司 | 胎儿遗传异常的无创性检测 |
| US10424394B2 (en) | 2011-10-06 | 2019-09-24 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| CA2850785C (en) | 2011-10-06 | 2022-12-13 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9367663B2 (en) | 2011-10-06 | 2016-06-14 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US10196681B2 (en) | 2011-10-06 | 2019-02-05 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9984198B2 (en) | 2011-10-06 | 2018-05-29 | Sequenom, Inc. | Reducing sequence read count error in assessment of complex genetic variations |
| JP6431769B2 (ja) | 2012-01-20 | 2018-11-28 | セクエノム， インコーポレイテッド | 実験条件を要因として含める診断プロセス |
| US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
| US10504613B2 (en) | 2012-12-20 | 2019-12-10 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US10497461B2 (en) | 2012-06-22 | 2019-12-03 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US10482994B2 (en) | 2012-10-04 | 2019-11-19 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US20130309666A1 (en) | 2013-01-25 | 2013-11-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| CA2901460A1 (en) | 2013-02-20 | 2014-08-28 | Bionano Genomics, Inc. | Characterization of molecules in nanofluidics |
| WO2015130696A1 (en) | 2014-02-25 | 2015-09-03 | Bionano Genomics, Inc. | Reduction of bias in genomic coverage measurements |
| US10844424B2 (en) | 2013-02-20 | 2020-11-24 | Bionano Genomics, Inc. | Reduction of bias in genomic coverage measurements |
| WO2014133369A1 (ko) * | 2013-02-28 | 2014-09-04 | 주식회사 테라젠이텍스 | 유전체 서열분석을 이용한 태아 염색체 이수성의 진단 방법 및 장치 |
| PL2981921T3 (pl) * | 2013-04-03 | 2023-05-08 | Sequenom, Inc. | Metody i procesy nieinwazyjnej oceny zmienności genetycznych |
| AU2014268377B2 (en) * | 2013-05-24 | 2020-10-08 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| CA2898747C (en) * | 2013-06-13 | 2021-09-21 | Ariosa Diagnostics, Inc. | Statistical analysis for non-invasive sex chromosome aneuploidy determination |
| US10622094B2 (en) * | 2013-06-21 | 2020-04-14 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| IL320112A (en) * | 2013-10-04 | 2025-06-01 | Sequenom Inc | Methods and processes for non-invasive assessment of genetic variations |
| WO2015054080A1 (en) | 2013-10-07 | 2015-04-16 | Sequenom, Inc. | Methods and processes for non-invasive assessment of chromosome alterations |
| WO2015061359A1 (en) | 2013-10-21 | 2015-04-30 | Verinata Health, Inc. | Method for improving the sensitivity of detection in determining copy number variations |
| CN103525939B (zh) * | 2013-10-28 | 2015-12-02 | 博奥生物集团有限公司 | 无创检测胎儿染色体非整倍体的方法和系统 |
| IL249095B2 (en) | 2014-05-30 | 2023-10-01 | Verinata Health Inc | Detection of subchromosomal aneuploidy in the fetus and variations in the number of copies |
| CN104156631B (zh) * | 2014-07-14 | 2017-07-18 | 天津华大基因科技有限公司 | 染色体三倍体检验方法 |
| WO2016010401A1 (ko) * | 2014-07-18 | 2016-01-21 | 에스케이텔레콘 주식회사 | 산모의 혈청 dna를 이용한 태아의 단일유전자 유전변이의 예측방법 |
| EP3760739B1 (en) | 2014-07-30 | 2025-09-03 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| CN106795551B (zh) * | 2014-09-26 | 2020-11-20 | 深圳华大基因股份有限公司 | 单细胞染色体的cnv分析方法和检测装置 |
| WO2016094853A1 (en) | 2014-12-12 | 2016-06-16 | Verinata Health, Inc. | Using cell-free dna fragment size to determine copy number variations |
| CN104789466B (zh) * | 2015-05-06 | 2018-03-13 | 安诺优达基因科技(北京)有限公司 | 检测染色体非整倍性的试剂盒和装置 |
| BE1022789B1 (nl) | 2015-07-17 | 2016-09-06 | Multiplicom Nv | Werkwijze en systeem voor geslachtsinschatting van een foetus van een zwangere vrouw |
| KR101817785B1 (ko) * | 2015-08-06 | 2018-01-11 | 이원다이애그노믹스(주) | 다양한 플랫폼에서 태아의 성별과 성염색체 이상을 구분할 수 있는 새로운 방법 |
| KR101678962B1 (ko) | 2015-08-21 | 2016-12-06 | 이승재 | 대규모 병렬형 게놈서열분석 방법을 이용한 비침습적 산전검사 장치 및 방법 |
| WO2017051996A1 (ko) * | 2015-09-24 | 2017-03-30 | 에스케이텔레콤 주식회사 | 비침습적 태아 염색체 이수성 판별 방법 |
| CN105354443A (zh) * | 2015-12-14 | 2016-02-24 | 孔祥军 | 无创产前基因检测分析软件 |
| CN105483229B (zh) * | 2015-12-21 | 2018-10-16 | 广东腾飞基因科技股份有限公司 | 一种检测胎儿染色体非整倍体的方法及系统 |
| KR101817180B1 (ko) * | 2016-01-20 | 2018-01-10 | 이원다이애그노믹스(주) | 염색체 이상 판단 방법 |
| US10095831B2 (en) * | 2016-02-03 | 2018-10-09 | Verinata Health, Inc. | Using cell-free DNA fragment size to determine copy number variations |
| JP6765433B2 (ja) * | 2016-02-12 | 2020-10-07 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 異常な核型の検出のための方法 |
| JP6785068B2 (ja) * | 2016-05-31 | 2020-11-18 | 富士フイルム株式会社 | 生物情報解析方法 |
| CN106096330B (zh) * | 2016-05-31 | 2019-02-01 | 北京百迈客医学检验所有限公司 | 一种无创产前生物信息检测分析方法 |
| US11200963B2 (en) | 2016-07-27 | 2021-12-14 | Sequenom, Inc. | Genetic copy number alteration classifications |
| EP3574424A1 (en) | 2017-01-24 | 2019-12-04 | Sequenom, Inc. | Methods and processes for assessment of genetic variations |
| WO2018137141A1 (zh) | 2017-01-24 | 2018-08-02 | 深圳华大基因研究院 | 基于外泌体dna进行无创产前诊断的方法及其应用 |
| WO2018170511A1 (en) | 2017-03-17 | 2018-09-20 | Sequenom, Inc. | Methods and processes for assessment of genetic mosaicism |
| EP3601591A1 (en) * | 2017-03-31 | 2020-02-05 | Premaitha Limited | Method of detecting a fetal chromosomal abnormality |
| US11342047B2 (en) | 2017-04-21 | 2022-05-24 | Illumina, Inc. | Using cell-free DNA fragment size to detect tumor-associated variant |
| EP4650456A2 (en) | 2018-01-05 | 2025-11-19 | BillionToOne, Inc. | Quality control templates for ensuring validity of sequencing-based assays |
| CN111868254A (zh) * | 2018-04-09 | 2020-10-30 | 深圳华大生命科学研究院 | 基因文库的构建方法及其应用 |
| CN111918965A (zh) * | 2018-04-28 | 2020-11-10 | 深圳华大生命科学研究院 | 一种胎儿游离核酸的富集方法及其应用 |
| CN111373054B (zh) * | 2018-05-31 | 2024-06-25 | 深圳华大临床检验中心 | 确定男性待测样本是否存在三倍体的方法、系统和计算机可读介质 |
| CN109192243B (zh) * | 2018-08-13 | 2021-03-12 | 成都凡迪医学检验所有限公司 | 染色体比例的修正方法、装置、介质 |
| CA3111813A1 (en) * | 2018-09-07 | 2020-03-12 | Illumina, Inc. | A method to determine if a circulating fetal cell isolated from a pregnant mother is from either the current or a historical pregnancy |
| KR20200106643A (ko) | 2019-03-05 | 2020-09-15 | (주)인실리코젠 | 바코드 서열 정보 기반 고민감도 유전변이 탐지 및 레포팅 시스템 |
| WO2020226528A1 (ru) * | 2019-05-08 | 2020-11-12 | Общество с ограниченной ответственностью "ГЕНОТЕК ИТ" | Способ определения кариотипа плода беременной женщины |
| CN110211654A (zh) * | 2019-05-30 | 2019-09-06 | 湖南自兴智慧医疗科技有限公司 | 一种自动隐藏性别信息的核型检测系统及方法 |
| CN111627498B (zh) * | 2020-05-21 | 2022-10-04 | 北京吉因加医学检验实验室有限公司 | 一种测序数据gc偏向性校正的方法及其装置 |
| US20240355415A1 (en) * | 2021-09-03 | 2024-10-24 | Institut National De La Sante Et De La Recherche Medicale | Methods and devices for non-invasive prenatal testing |
| KR20250019610A (ko) | 2022-03-21 | 2025-02-10 | 빌리언투원, 인크. | 치료 모니터링을 위한 메틸화된 세포 유리 dna의 분자 계수 |
| WO2025208288A1 (zh) * | 2024-04-01 | 2025-10-09 | 深圳华大生命科学研究院 | 基因预测方法、装置、计算机设备及计算机可读存储介质 |
| CN119936386B (zh) * | 2025-01-21 | 2025-12-16 | 北京航空航天大学杭州创新研究院 | 一种单分子免疫检测原料及其检测方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10021A (en) * | 1853-09-13 | Screw-eastemtito- for boots and shoes | ||
| GB9704444D0 (en) | 1997-03-04 | 1997-04-23 | Isis Innovation | Non-invasive prenatal diagnosis |
| US20010051341A1 (en) | 1997-03-04 | 2001-12-13 | Isis Innovation Limited | Non-invasive prenatal diagnosis |
| USRE39920E1 (en) | 1997-05-30 | 2007-11-13 | Xenomics, Inc. | Methods for detection of nucleic acid sequences in urine |
| DK0920539T3 (da) | 1997-05-30 | 2006-07-24 | Xenomics | Fremgangsmåder til detektion af nukleinsyresekvenser i urin |
| US20020119478A1 (en) | 1997-05-30 | 2002-08-29 | Diagen Corporation | Methods for detection of nucleic acid sequences in urine |
| US6492144B1 (en) | 1997-05-30 | 2002-12-10 | Diagen Corporation | Methods for detection of nucleic acid sequences in urine |
| US20070087345A1 (en) | 2003-07-10 | 2007-04-19 | Third Wave Technologies, Inc. | Assays for the direct measurement of gene dosage |
| ATE435301T1 (de) | 2003-10-16 | 2009-07-15 | Sequenom Inc | Nicht invasiver nachweis fötaler genetischer merkmale |
| US20100216151A1 (en) | 2004-02-27 | 2010-08-26 | Helicos Biosciences Corporation | Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities |
| US20060046258A1 (en) | 2004-02-27 | 2006-03-02 | Lapidus Stanley N | Applications of single molecule sequencing |
| US20100216153A1 (en) * | 2004-02-27 | 2010-08-26 | Helicos Biosciences Corporation | Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities |
| ES2739484T3 (es) | 2006-02-02 | 2020-01-31 | Univ Leland Stanford Junior | Prueba genética fetal no invasiva mediante análisis digital |
| US20100184044A1 (en) | 2006-02-28 | 2010-07-22 | University Of Louisville Research Foundation | Detecting Genetic Abnormalities |
| US20100184043A1 (en) | 2006-02-28 | 2010-07-22 | University Of Louisville Research Foundation | Detecting Genetic Abnormalities |
| CA2647793C (en) | 2006-02-28 | 2016-07-05 | University Of Louisville Research Foundation | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
| WO2007112418A2 (en) | 2006-03-28 | 2007-10-04 | Baylor College Of Medicine | Screening for down syndrome |
| WO2009035447A1 (en) | 2006-06-14 | 2009-03-19 | Living Microsystems, Inc. | Diagnosis of fetal abnormalities by comparative genomic hybridization analysis |
| US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
| EP2589668A1 (en) | 2006-06-14 | 2013-05-08 | Verinata Health, Inc | Rare cell analysis using sample splitting and DNA tags |
| US20080070792A1 (en) | 2006-06-14 | 2008-03-20 | Roland Stoughton | Use of highly parallel snp genotyping for fetal diagnosis |
| US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
| US20080090239A1 (en) | 2006-06-14 | 2008-04-17 | Daniel Shoemaker | Rare cell analysis using sample splitting and dna tags |
| CN108048549B (zh) | 2006-06-14 | 2021-10-26 | 维里纳塔健康公司 | 使用样品拆分和dna标签进行稀有细胞分析 |
| WO2008014516A2 (en) | 2006-07-28 | 2008-01-31 | Living Microsystems, Inc. | Selection of cells using biomarkers |
| EP2140027B1 (en) | 2006-12-07 | 2012-07-18 | Novartis AG | Non-invasive prenatal genetic screen |
| EP3892736A1 (en) | 2007-07-23 | 2021-10-13 | The Chinese University of Hong Kong | Determining a nucleic acid sequence imbalance |
| US12180549B2 (en) | 2007-07-23 | 2024-12-31 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using genomic sequencing |
| EP2952589B1 (en) | 2008-09-20 | 2018-02-14 | The Board of Trustees of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
| CN103403183B (zh) | 2011-06-29 | 2014-10-15 | 深圳华大基因医学有限公司 | 胎儿遗传异常的无创性检测 |
-
2011
- 2011-06-29 CN CN201180067286.XA patent/CN103403183B/zh active Active
- 2011-06-29 CA CA2791118A patent/CA2791118C/en active Active
- 2011-06-29 SI SI201130281T patent/SI2561103T1/sl unknown
- 2011-06-29 RU RU2012158107/15A patent/RU2589681C2/ru active
- 2011-06-29 EP EP11863253.8A patent/EP2561103B1/en active Active
- 2011-06-29 AU AU2012261664A patent/AU2012261664B2/en active Active
- 2011-06-29 SG SG2013049317A patent/SG191757A1/en unknown
- 2011-06-29 BR BR112012033760-2A patent/BR112012033760B1/pt active IP Right Grant
- 2011-06-29 ES ES11863253.8T patent/ES2512448T3/es active Active
- 2011-06-29 KR KR1020127034453A patent/KR101489568B1/ko active Active
- 2011-06-29 CA CA2948939A patent/CA2948939C/en active Active
- 2011-06-29 WO PCT/CN2011/001070 patent/WO2013000100A1/en not_active Ceased
- 2011-06-29 JP JP2014517369A patent/JP5659319B2/ja active Active
- 2011-06-29 DK DK11863253.8T patent/DK2561103T3/da active
- 2011-06-29 PL PL11863253T patent/PL2561103T3/pl unknown
- 2011-06-29 US US13/641,080 patent/US9547748B2/en active Active
- 2011-06-29 MY MYPI2012005470A patent/MY172864A/en unknown
-
2012
- 2012-12-18 ZA ZA2012/09583A patent/ZA201209583B/en unknown
Non-Patent Citations (1)
| Title |
|---|
| FAN H.C. et al. Sensitivity of Noninvasive Prenatal Detection of Fetal Aneuploidy from Maternal Plasma Using Shotgun Sequencing Is Limited Only by Counting Statistics. PLoS One. 2010 May 3; 5(5): e10439 [Найдено 09.04.2015] [он-лайн]. Найдено из Интернет: URL: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010439. FAN H.C. et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A. 2008 Oct 21;105 (42): 16266-16271. Epub 2008 Oct 6 [Найдено 09.04.2015] [он-лайн], Найдено из Интернет: URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562413/. ДВОРКИН М.Э. Методы минимизации необходимого числа цепей для секвенирования ДНК. СПбГУ ИТМО. Кафедра компьютерных технологий. СПб. 2010; стр.1-44 [Найдено 04.03.2014] [он-лайн], Найдено из Интернет: URL: http://is.ifmo.ru/diploma-theses/_dvorkin_genom.pdf. * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2752783C1 (ru) * | 2020-12-18 | 2021-08-03 | Федеральное государственное бюджетное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Министерства здравоохранения Российской Федерации | Способ прогнозирования анеуплоидии эмбрионов в программе экстракорпорального оплодотворения у женщин с эндометриоз-ассоциированным бесплодием |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201209583B (en) | 2014-01-29 |
| WO2013000100A1 (en) | 2013-01-03 |
| PL2561103T3 (pl) | 2015-02-27 |
| CN103403183A (zh) | 2013-11-20 |
| ES2512448T3 (es) | 2014-10-24 |
| US9547748B2 (en) | 2017-01-17 |
| JP2014520509A (ja) | 2014-08-25 |
| CN103403183B (zh) | 2014-10-15 |
| HK1190758A1 (en) | 2014-07-11 |
| EP2561103B1 (en) | 2014-08-27 |
| RU2012158107A (ru) | 2015-08-10 |
| KR101489568B1 (ko) | 2015-02-03 |
| AU2012261664B2 (en) | 2014-07-03 |
| CA2791118A1 (en) | 2012-12-29 |
| CA2791118C (en) | 2019-05-07 |
| EP2561103A1 (en) | 2013-02-27 |
| SI2561103T1 (sl) | 2014-11-28 |
| CA2948939A1 (en) | 2012-12-29 |
| US20140099642A1 (en) | 2014-04-10 |
| BR112012033760A2 (pt) | 2018-02-27 |
| MY172864A (en) | 2019-12-13 |
| CA2948939C (en) | 2021-02-02 |
| KR20140023847A (ko) | 2014-02-27 |
| SG191757A1 (en) | 2013-08-30 |
| AU2012261664A1 (en) | 2013-01-17 |
| EP2561103A4 (en) | 2013-08-07 |
| JP5659319B2 (ja) | 2015-01-28 |
| BR112012033760B1 (pt) | 2020-11-17 |
| DK2561103T3 (da) | 2014-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2589681C2 (ru) | Неинвазивное обнаружение генетической аномалии плода | |
| CN104120181B (zh) | 对染色体测序结果进行gc校正的方法及装置 | |
| JP6513622B2 (ja) | 非侵襲的出生前診断に有用な母体試料由来の胎児核酸のメチル化に基づく富化のためのプロセスおよび組成物 | |
| TWI641834B (zh) | 藉由大量平行ｒｎａ定序之母體血漿轉錄體分析 | |
| US8682594B2 (en) | Noninvasive diagnosis of fetal aneuploidy by sequencing | |
| US20210002728A1 (en) | Systems and methods for detection of residual disease | |
| US7416851B2 (en) | Method of diagnosis/prognosis of human chronic lymphocytic leukemia comprising the profiling of LPL/ADAM genes | |
| HUE030510T2 (hu) | Magzati kromoszómális aneuploidia diagnosztizálása genomszekvenálás alkalmazásával | |
| US20210065842A1 (en) | Systems and methods for determining tumor fraction | |
| KR20150082228A (ko) | 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정 | |
| WO2019025004A1 (en) | METHOD FOR NON-INVASIVE PRENATAL DETECTION OF FETUS SEX CHROMOSOMAL ABNORMALITY AND FETUS SEX DETERMINATION FOR SINGLE PREGNANCY AND GEEMELLAR PREGNANCY | |
| EP4464791A1 (en) | Non-invasive in-vitro method for somatic mutation detection | |
| US11821036B2 (en) | Methods for identifying and monitoring pregnant women at risk of preeclampsia | |
| TWI489305B (zh) | 對胎兒遺傳異常的無創性檢測 | |
| Sillence | Cell-free fetal DNA (cffDNA) enrichment for non-invasive prenatal testing (NIPT): a comparison of molecular techniques | |
| HK1190758B (en) | Noninvasive detection of fetal genetic abnormality | |
| WO2025203031A2 (en) | Methods of cancer detection by discordant methylation in cfdna | |
| HK1233684A1 (en) | Methylation pattern analysis of tissues in dna mixture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HZ9A | Changing address for correspondence with an applicant |